Peter McNamara, Chief Scientific Officer of Tectonic Therapeutic ($TECX), made four open market sales of company shares in the past year, totaling $266,562. His most recent TECX insider sale occurred on March 6, 2026. These transactions rank 7,819th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. McNamara recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Employee Stock Option (Right to Buy) | 215 | $0.00 | 8,045.0000 | 18,716,280 | 2.60% | 0.00% |
| March 6, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Employee Stock Option (Right to Buy) | 2500 | $0.00 | 31,959.0000 | 18,716,280 | 7.25% | 0.01% |
| March 6, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | S | Common Stock | 215 | $35.00 | 55,285.0000 | 18,716,280 | 0.39% | 0.00% |
| March 6, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | S | Common Stock | 6047 | $30.00 | 55,500.0000 | 18,716,280 | 9.83% | 0.03% |
| March 6, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Common Stock | 215 | $14.71 | 61,547.0000 | 18,716,280 | 0.35% | 0.00% |
| March 6, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Common Stock | 2500 | $2.38 | 61,332.0000 | 18,716,280 | 4.25% | 0.01% |
| March 3, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | S | Common Stock | 1649 | $22.06 | 37,482.0000 | 18,716,280 | 4.21% | 0.01% |
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 18,716,280 | 9999.99% | 0.11% |
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | S | Common Stock | 1650 | $25.00 | 58,832.0000 | 18,716,280 | 2.73% | 0.01% |
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Common Stock | 23000 | $0.00 | 60,482.0000 | 18,716,280 | 61.36% | 0.12% |
| Feb. 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | F | Common Stock | 1748 | $23.22 | 39,131.0000 | 18,716,280 | 4.28% | 0.01% |
| Dec. 22, 2025 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Employee Stock Option (Right to Buy) | 7000 | $0.00 | 25,065.0000 | 18,716,280 | 21.83% | 0.04% |
| Dec. 22, 2025 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Common Stock | 7000 | $2.98 | 40,879.0000 | 18,716,280 | 20.66% | 0.04% |
| Sept. 25, 2025 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Common Stock | 4550 | $0.00 | 33,879.0000 | 18,662,672 | 15.51% | 0.02% |
| Sept. 25, 2025 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 8260 | $0.00 | 8,260.0000 | 18,662,672 | 9999.99% | 0.04% |
| Feb. 4, 2025 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Common Stock | 15141 | $0.00 | 29,329.0000 | 0 | 106.72% | 0.00% |
| Feb. 4, 2025 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 27530 | $0.00 | 27,530.0000 | 0 | 9999.99% | 0.00% |
| Dec. 3, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Common Stock | 3500 | $2.38 | 14,188.0000 | 0 | 32.75% | 0.00% |
| Dec. 3, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | M | Employee Stock Option (Right to Buy) | 3500 | $0.00 | 34,459.0000 | 0 | 9.22% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 37959 | $0.00 | 37,959.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 18704 | $0.00 | 18,704.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 77000 | $0.00 | 77,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Common Stock | 10688 | $0.00 | 10,688.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | McNamara Peter | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 32065 | $0.00 | 32,065.0000 | 0 | 9999.99% | 0.00% |